Evidence map›Paper›PMID 35117684›Full record

ArticleTranslational cancer research2020

Chenge Shen, Beixi Wang, Kaiwen Zhang, Ce Wang, Jiajia Wang, Zhanglu An, Lisha Shu

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Microrna Expression inMicroRNA (Shariqah, United Arab Emirates) · 2026
    Article
  2. Biology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chenge ShenDepartment of Obstetrics and Gynecology, Hebei North University, Zhangjiakou 075000, China.
Beixi WangDepartment of Pathology, Xinxiang Medical University, Xinxiang 453003, China.
Kaiwen ZhangDepartment of Obstetrics and Gynecology, Zhengzhou University, Zhengzhou 450000, China.
Ce WangDepartment of Human Anatomy and Histology and Embryology, Hebei North University, Zhangjiakou 075000, China.
Jiajia WangDepartment of Pathology, Hebei North University, Zhangjiakou 075000, China.
Zhanglu AnDepartment of Obstetrics and Gynecology, Hebei North University, Zhangjiakou 075000, China.
Lisha ShuDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China.
Hebei North University · CNXinxiang Medical University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRGMB antisense RNA 1 (

methodsThe expressions of

results

conclusions

Indexed as

cervical cancer (CC)microRNA-4428 (miR-4428)PBX homeobox 1 (PBX1)RGMB antisense RNA 1 (RGMB-AS1)

Identifiers

PMID35117684
PMCPMC8798374
OpenAlexW3023406191

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.